Human blood platelets exposed to complement proteins C5b-9 show increased metabolic conversion of arachidonate through the cyclo-oxygenase pathway and an enhanced secretory response to thrombin. Plasma membrane damage by these pore-forming serum proteins has also been implicated in episodes of vascular thrombosis associated with immunologic disease. The research outlined in this Proposal investigates the molecular events underlying this sublytic interaction of the C5b-9 proteins with the human platelet, with the overall goal of identifying how their insertion into the plasma membrane of this cell alters or bypasses normal transduction processes accompanying platelet activation, and potentially triggers vascular thrombotic reactions. Using gel-filtered platelets exposed to the purified C5b-9 proteins, we aim specifically (i) to measure changes in plasma membrane conductance initiated by C5b-9 assembly on the platelet surface; (ii) to identify the compensatory responses of the platelet that enable this cell to escape lytic plasma membrane rupture after formation of the C5b-9 pore, thereby sustaining its secretory and aggregation responses; (iii) to determine how electrochemical changes in the platelet initiated by the membrane-inserted C5b-9 proteins is related to changes in arachidonate metabolism, lysosomal enzyme release and stimulus-secretion coupling, as well as to selective shedding of plasma membrane components from the platelet surface. In these experiments, time-dependent changes in membrane potential, intracellular Ca++, and internal pH will be monitored with fluorimetric indicators and related to measured transmembrane ion fluxes. Concomitant changes in phospholipid metabolism and granule secretion will be assessed by isotopic, fluorimetric and radioimmunoassay methods. Plasma membrane vesicles released from the platelet surface in response to C5b-9 insertion will be isolated and characterized with respect to composition and """"""""sidedness"""""""" (with respect to the plasma membrane), and the conformational state of the C5b-9 proteins associated with these membrane vesicles defined. The effects of the membrane-inserted C5b-9 proteins on assembly and function of the platelet prothrombinase complex will be examined as a mechanism for increased prothrombin converting activity after immunologic damage. It is proposed that the information derived from these studies will provide new insight into the molecular events that are initiated upon C5b-9 binding to the surface of this key hemostatic blood cell, and contribute to an understanding of the potential role of these serum proteins in the pathogenesis of thrombotic vascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036946-04
Application #
3352343
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1986-12-01
Project End
1991-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Kirov, Aleksandr; Al-Hashimi, Huda; Solomon, Phil et al. (2012) Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1. J Cell Biochem 113:956-66
Chen, Chun-Wei; Sowden, Mark; Zhao, Qian et al. (2011) Nuclear phospholipid scramblase 1 prolongs the mitotic expansion of granulocyte precursors during G-CSF-induced granulopoiesis. J Leukoc Biol 90:221-33
Bateman, Alex; Finn, Robert D; Sims, Peter J et al. (2009) Phospholipid scramblases and Tubby-like proteins belong to a new superfamily of membrane tethered transcription factors. Bioinformatics 25:159-62
Lu, Biao; Sims, Peter J; Wiedmer, Therese et al. (2007) Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. Biochim Biophys Acta 1771:1177-85
Huang, Y; Zhao, Q; Zhou, C-X et al. (2006) Antileukemic roles of human phospholipid scramblase 1 gene, evidence from inducible PLSCR1-expressing leukemic cells. Oncogene 25:6618-27
Li, Youjun; Rogulski, Kenneth; Zhou, Quansheng et al. (2006) The negative c-Myc target onzin affects proliferation and apoptosis via its obligate interaction with phospholipid scramblase 1. Mol Cell Biol 26:3401-13
Chen, Min-Hsuan; Ben-Efraim, Iris; Mitrousis, Gregory et al. (2005) Phospholipid scramblase 1 contains a nonclassical nuclear localization signal with unique binding site in importin alpha. J Biol Chem 280:10599-606
Zhou, Quansheng; Ben-Efraim, Iris; Bigcas, Jo-Lawrence et al. (2005) Phospholipid scramblase 1 binds to the promoter region of the inositol 1,4,5-triphosphate receptor type 1 gene to enhance its expression. J Biol Chem 280:35062-8
Wiedmer, Therese; Zhao, Ji; Li, Lilin et al. (2004) Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci U S A 101:13296-301
Zhao, Ke-Wen; Li, Xi; Zhao, Qian et al. (2004) Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood 104:3731-8

Showing the most recent 10 out of 57 publications